Horn, Lucas A.
Lind, Hanne
Fousek, Kristen
Qin, Haiyan
Rajabian, Nika
Angstadt, Shantel
Hsiao-Sanchez, Nicole
Medina-Enriquez, Miriam M.
Kelly, Marcus D.
Allen, Clint T.
Hammoudeh, Sarah M.
Weigert, Roberto
Maeda, Dean Y.
Zebala, John A.
Palena, Claudia
Funding for this research was provided by:
National Cancer Institute
Article History
Received: 21 August 2024
Accepted: 25 November 2024
First Online: 5 December 2024
Declarations
:
: All animal procedures reported in this study were approved by the NCI Animal Care and Use Committee (ACUC) and in accordance with federal regulatory requirements and standards. All components of the intramural NIH ACU program are accredited by Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.
: Not applicable.
: The authors from Syntrix Pharmaceuticals are employees or officers of the company. CP discloses spouse’s employment and holdings in MacroGenics, Inc. All other authors from the National Cancer Institute, NIH, do not have any competing interests to disclose.The NCI, NIH has an ongoing Cooperative Research and Development Agreement (CRADA) with Syntrix Pharmaceuticals.